Acorda Therapeutics (ACOR) News Today → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free ACOR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisEarningsHeadlinesInsider TradesOwnershipShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16, 2024 | msn.comEssential cancer treatment company files Chapter 11 bankruptcyApril 15, 2024 | businesswire.comAcorda Therapeutics Announces Delisting from NasdaqApril 14, 2024 | wsj.comAcorda Therapeutics Inc.April 8, 2024 | msn.comPearl River-based Acorda Therapeutics to close; 97 jobs impactedApril 6, 2024 | finance.yahoo.comRiskiest Junk Bonds Shunned in Europe on Rising Risk of DefaultApril 3, 2024 | businesswire.comAcorda Therapeutics Announces Nasdaq Delisting NotificationApril 3, 2024 | baystreet.caAcorda Therapeutics Files for Chapter 11 BankruptcyApril 2, 2024 | msn.comCrude Oil Surges Over 1%; US Factory Orders Increase In FebruaryApril 2, 2024 | benzinga.comWhy Acorda Therapeutics Stock Is Down Nearly 90%April 2, 2024 | marketbeat.comTrading was temporarily halted for "ACOR" at 11:04 AM with a stated reason of "LULD pause."April 2, 2024 | marketbeat.comTrading was temporarily halted for "ACOR" at 11:04 AM with a stated reason of "LULD pause."April 2, 2024 | marketbeat.comTrading was temporarily halted for "ACOR" at 10:04 AM with a stated reason of "LULD pause."April 2, 2024 | marketbeat.comTrading was temporarily halted for "ACOR" at 10:04 AM with a stated reason of "LULD pause."April 2, 2024 | marketbeat.comTrading was temporarily halted for "ACOR" at 10:04 AM with a stated reason of "LULD pause."April 2, 2024 | investorplace.comWhy Is Acorda Therapeutics (ACOR) Stock Down 72% Today?April 2, 2024 | morningstar.comNorth American Morning Briefing: Stocks Seen Weaker as Doubts Over Fed Cuts MountApril 2, 2024 | finanznachrichten.deMerz Therapeutics: Merz Enters Asset Purchase Agreement With a US-Based Biotech CompanyApril 1, 2024 | msn.comAcorda retires from PNP after 3 months of extended serviceApril 1, 2024 | msn.comRetired PNP chief Acorda: I did my bestApril 1, 2024 | marketwatch.comStocks to Watch: PVH, Canoo, Acorda TherapeuticsApril 1, 2024 | msn.comAcorda Therapeutics shares sink nearly 40% after bankruptcy filingApril 1, 2024 | finance.yahoo.comAcorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024March 26, 2024 | finance.yahoo.comAcorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024March 11, 2024 | finance.yahoo.comKlick Health Launches First AI Social Media Comment Moderator for Life Sciences IndustryFebruary 28, 2024 | stocknews.com3 Biotech Stocks to Watch in March for SuccessFebruary 23, 2024 | benzinga.comAcorda Therapeutics Stock (NASDAQ:ACOR), Short Interest ReportFebruary 22, 2024 | benzinga.comAcorda Therapeutics Stock (NASDAQ:ACOR) Dividends: History, Yield and DatesFebruary 20, 2024 | msn.comAcorda: No policy vs. TikTok use in PNPFebruary 6, 2024 | msn.comAcorda: PNP can’t interfere with people’s initiative for Charter changeFebruary 5, 2024 | msn.comTeodoro, Acorda nix Mindanao separation from PhilippinesJanuary 31, 2024 | msn.comPNP chief Acorda tells ranks: Ignore ‘political noise’January 29, 2024 | finance.yahoo.comDementia and Movement Disorder Treatment Market to Grow by USD 8.55 billion, Market Share, Trends, and Growth Analysis - TechnavioJanuary 11, 2024 | markets.businessinsider.comAcorda Therapeutics To Regain Worldwide Commercialization Rights To FAMPYRAJanuary 10, 2024 | stocknews.com3 Biotech Stocks to Keep an Eye on in 2024January 8, 2024 | msn.comAcorda files raps vs person spreading false info in viral vlogJanuary 8, 2024 | msn.comAcorda slams vlogger in 'disinformation' driveJanuary 8, 2024 | msn.comAcorda files cybercrime raps vs person spreading false info in a vlogJanuary 7, 2024 | msn.comAcorda eyes Pinoy apps vs cybercrimesJanuary 6, 2024 | morningstar.comAcorda Therapeutics Inc ACORJanuary 4, 2024 | finance.yahoo.comAshvattha Therapeutics Announces the Appointment of Mehdi Paborji as Senior Vice President of Technical OperationsDecember 18, 2023 | stocknews.comModerna (MRNA) and Acorda Therapeutics (ACOR): Buy, Hold, or Sell in 2024?December 18, 2023 | finance.yahoo.comAcorda Therapeutics, Inc.'s (NASDAQ:ACOR) Shares Bounce 53% But Its Business Still Trails The IndustryDecember 15, 2023 | stocknews.com3 Biotech Stocks Flashing Year-End 'Buy' Signals"November 24, 2023 | stocknews.com3 Safe Biotech Stocks to Buy This WeekNovember 14, 2023 | finance.yahoo.comAcorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | msn.comAcorda Therapeutics GAAP EPS of -$7.16, revenue of $27.72MNovember 13, 2023 | finance.yahoo.comAcorda Therapeutics Reports Third Quarter 2023 Financial ResultsNovember 8, 2023 | msn.comAcorda to PNP: Remain firm, united amid destabilization talkNovember 6, 2023 | finance.yahoo.comAcorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023November 6, 2023 | msn.comAcorda: Probe on missing beauty queen yielding significant progress Get Acorda Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOR and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ACOR Media Mentions By Week ACOR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACOR News Sentiment▼0.000.79▲Average Medical News Sentiment ACOR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACOR Articles This Week▼01▲ACOR Articles Average Week Get Acorda Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SQZ News Today WINT News Today ELOX News Today ALBT News Today AKAN News Today SPRC News Today SBFM News Today BBLG News Today VRPX News Today BLPH News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACOR) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyNvidia is about to pass AppleWeiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe Worst is Yet to Come…Porter & CompanyDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acorda Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
